Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00243464
Status:
COMPLETED
Last Update Posted:
2015-03-26
First Post:
2005-10-21
Brief Title:
Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Study Overview
Official Title:
Calcipotriol Plus Betamethasone Dipropionate Gel Compared to DAIVONEXDOVONEX Scalp Solution in Patients With Scalp Psoriasis
Status:
COMPLETED
Status Verified Date:
2015-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of calcipotriol plus betamethasone dipropionate gel is more effective than twice daily treatment of calcipotriol scalp solution in patients with scalp psoriasis The primary outcome is patients with clear or minimal disease after 8 weeks treatment
Further the occurrence of relapse and rebound after end of treatment in patients with clear or minimal disease will be investigated
Further the occurrence of relapse and rebound after end of treatment in patients with clear or minimal disease will be investigated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None